Successful treatment of donor-derived hepatitis C infection in a lung transplant recipient

被引:13
|
作者
Theodoropoulos, Nicole [1 ]
Whitson, Bryan A. [2 ]
Martin, Stanley I. [3 ]
Pouch, Stephanie [4 ]
Pope-Harman, Amy [5 ]
机构
[1] UMass Mem Med Ctr, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA
[2] Ohio State Univ, Dept Surg, Div Cardiac Surg, Columbus, OH 43210 USA
[3] Geisinger Hlth Syst, Divs Infect Dis, Danville, PA USA
[4] OSU, Div Infect Dis, Dept Internal Med, Columbus, OH USA
[5] OSU, Div Pulm Allergy Crit Care & Sleep Med, Dept Internal Med, Columbus, OH USA
关键词
direct-acting antivirals; donor-derived infection; hepatitis C; lung transplant; HUMAN-IMMUNODEFICIENCY-VIRUS; GENOTYPE; ORGAN; TRANSMISSION; SOFOSBUVIR; SIMEPREVIR; RIBAVIRIN;
D O I
10.1111/tid.12659
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Data are limited regarding the use of direct-acting antivirals for treatment of hepatitis C infection post lung transplant, especially in a donor-derived infection. We present a case of a lung transplant recipient with donor-derived hepatitis C that was successfully treated with a 12-week regimen of simeprevir and sofosbuvir. This case reiterates the importance of screening recipients of increased-risk donor organs for disease transmission and the value of early therapy.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Donor-Derived Disseminated Toxoplasmosis In Lung Transplant Recipient
    Gutteridge, D.
    Zaffiri, L.
    Duncan, M.
    Roe, D.
    Hage, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [2] Donor-Derived Bactrim Allergy in a Lung Transplant Recipient
    Olson, M. T.
    Walia, R.
    Strauel, S.
    Arjuna, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S296 - S296
  • [3] DONOR-DERIVED TUBERCULOSIS IN LUNG TRANSPLANT RECIPIENT: THE NEED OF DONOR SCREENING
    Pascale, Renato
    Salvaterra, Elena
    Maccaro, Angelo
    Podesta, Debora
    Tadolini, Marina
    Dolci, Giampiero
    Viale, Pierluigi
    Giannella, Maddalena
    TRANSPLANT INTERNATIONAL, 2021, 34 : 385 - 385
  • [4] Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens
    Shah, Ashesh P.
    Cameron, Andrew
    Singh, Pooja
    Frank, Adam M.
    Fenkel, Jonathan M.
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (02)
  • [5] DONOR-DERIVED STRONGYLOIDES STERCOLIS INFECTION IN A KIDNEY TRANSPLANT RECIPIENT
    Nagasunder, Arabhi
    Adeyemo, AdeSubomi
    Barba, Lilly
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S120 - S120
  • [6] Donor-Derived Disseminated Mycobacterium Tuberculosis Infection in a Lung Transplant Recipient Three Months After Transplant
    Calhoun, M.
    Roppo, H.
    Gray, L.
    Steele, P.
    Smith, J. B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S540 - S541
  • [7] Respiratory Failure due to Possible Donor-Derived Sporothrix schenckii Infection in a Lung Transplant Recipient
    Bahr, Nathan C.
    Janssen, Katherine
    Billings, Joanne
    Loor, Gabriel
    Green, Jaime S.
    CASE REPORTS IN INFECTIOUS DISEASES, 2015, 2015
  • [8] The Effect of Donor-Derived Herpes Viruses on Lung Transplant Recipient Survival
    Strah, H.
    Shindo, Y.
    Bricker, T. L.
    Aloush, A.
    Gelman, A. E.
    Green, J. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S288 - S288
  • [9] Donor-derived small cell lung carcinoma in a kidney transplant recipient
    Bodvarsson, S
    Burlingham, W
    Kusaka, S
    Hafez, GR
    Becker, BN
    Pintar, T
    Sollinger, HW
    Albertini, MR
    CANCER, 2001, 92 (09) : 2429 - 2434
  • [10] Donor and Recipient Hepatitis C Status in Lung Transplant
    Englum, B. R.
    Ganapathi, A. M.
    Speicher, P. J.
    Gulack, B. C.
    Lin, S. S.
    Palmer, S. M.
    Snyder, L. D.
    Daneshmand, M.
    Davis, R. D.
    Hartwig, M. G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S182 - S183